178 related articles for article (PubMed ID: 28101821)
1. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.
Truong H; Hegarty SE; Gomella LG; Kelly WK; Trabulsi EJ; Lallas CD; Giri VN
J Genet Couns; 2017 Jun; 26(3):548-555. PubMed ID: 28101821
[TBL] [Abstract][Full Text] [Related]
2. Application of the ACMG/NSGC genetic referral guidelines for hereditary renal cell carcinoma at the University of Miami, from 2014 to 2017.
Leuchter JD; Patel PM; Fourzali KM; Donenberg TR; Silva-Smith R; Vassallo NC; Blanton SH; Parekh DJ; Forghani I
Am J Med Genet A; 2021 Oct; 185(10):3012-3018. PubMed ID: 34152076
[TBL] [Abstract][Full Text] [Related]
3. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
Hampel H; Bennett RL; Buchanan A; Pearlman R; Wiesner GL;
Genet Med; 2015 Jan; 17(1):70-87. PubMed ID: 25394175
[TBL] [Abstract][Full Text] [Related]
4. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
[TBL] [Abstract][Full Text] [Related]
5. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
[TBL] [Abstract][Full Text] [Related]
6. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.
Shuch B; Vourganti S; Ricketts CJ; Middleton L; Peterson J; Merino MJ; Metwalli AR; Srinivasan R; Linehan WM
J Clin Oncol; 2014 Feb; 32(5):431-7. PubMed ID: 24378414
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.
Carlo MI; Mukherjee S; Mandelker D; Vijai J; Kemel Y; Zhang L; Knezevic A; Patil S; Ceyhan-Birsoy O; Huang KC; Redzematovic A; Coskey DT; Stewart C; Pradhan N; Arnold AG; Hakimi AA; Chen YB; Coleman JA; Hyman DM; Ladanyi M; Cadoo KA; Walsh MF; Stadler ZK; Lee CH; Feldman DR; Voss MH; Robson M; Motzer RJ; Offit K
JAMA Oncol; 2018 Sep; 4(9):1228-1235. PubMed ID: 29978187
[TBL] [Abstract][Full Text] [Related]
8. Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Bratslavsky G; Mendhiratta N; Daneshvar M; Brugarolas J; Ball MW; Metwalli A; Nathanson KL; Pierorazio PM; Boris RS; Singer EA; Carlo MI; Daly MB; Henske EP; Hyatt C; Middleton L; Morris G; Jeong A; Narayan V; Rathmell WK; Vaishampayan U; Lee BH; Battle D; Hall MJ; Hafez K; Jewett MAS; Karamboulas C; Pal SK; Hakimi AA; Kutikov A; Iliopoulos O; Linehan WM; Jonasch E; Srinivasan R; Shuch B
Cancer; 2021 Nov; 127(21):3957-3966. PubMed ID: 34343338
[TBL] [Abstract][Full Text] [Related]
9. Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.
Kotnik U; Peterlin B; Lovrecic L
BMC Cancer; 2021 Jun; 21(1):665. PubMed ID: 34082720
[TBL] [Abstract][Full Text] [Related]
10. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.
Hofmann JN; Schwartz K; Chow WH; Ruterbusch JJ; Shuch BM; Karami S; Rothman N; Wacholder S; Graubard BI; Colt JS; Purdue MP
Cancer Causes Control; 2013 Jan; 24(1):167-74. PubMed ID: 23179659
[TBL] [Abstract][Full Text] [Related]
11. Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors.
Rabbani F; Herr HW; Almahmeed T; Russo P
J Clin Oncol; 2002 May; 20(9):2370-5. PubMed ID: 11981010
[TBL] [Abstract][Full Text] [Related]
12. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
[TBL] [Abstract][Full Text] [Related]
13. Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.
Kallinikas G; Habib H; Tsimiliotis D; Koutsokostas E; Bokor B
Int Urol Nephrol; 2017 Sep; 49(9):1507-1512. PubMed ID: 28567709
[TBL] [Abstract][Full Text] [Related]
14. A case-control study of reproductive factors and renal cell carcinoma among black and white women in the United States.
Purdue MP; Colt JS; Graubard B; Davis F; Ruterbusch JJ; Digaetano R; Karami S; Wacholder S; Schwartz K; Chow WH
Cancer Causes Control; 2011 Nov; 22(11):1537-44. PubMed ID: 21866373
[TBL] [Abstract][Full Text] [Related]
15. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
Patel HD; Kates M; Pierorazio PM; Allaf ME
Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
[TBL] [Abstract][Full Text] [Related]
16. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
Chow WH; Shuch B; Linehan WM; Devesa SS
Cancer; 2013 Jan; 119(2):388-94. PubMed ID: 23147245
[TBL] [Abstract][Full Text] [Related]
17. Family history of cancer and renal cell cancer risk in Caucasians and African Americans.
Karami S; Schwartz K; Purdue MP; Davis FG; Ruterbusch JJ; Munuo SS; Wacholder S; Graubard BI; Colt JS; Chow WH
Br J Cancer; 2010 May; 102(11):1676-80. PubMed ID: 20442711
[TBL] [Abstract][Full Text] [Related]
18. Racial Disparities and Preventive Measures to Renal Cell Carcinoma.
Sims JN; Yedjou CG; Abugri D; Payton M; Turner T; Miele L; Tchounwou PB
Int J Environ Res Public Health; 2018 May; 15(6):. PubMed ID: 29843394
[TBL] [Abstract][Full Text] [Related]
19. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract][Full Text] [Related]
20. Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.
Paulucci DJ; Sfakianos JP; Skanderup AJ; Kan K; Tsao CK; Galsky MD; Hakimi AA; Badani KK
Oncotarget; 2017 Jan; 8(3):5196-5205. PubMed ID: 28029648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
